Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial. (2020)

First Author: Freeman TP
Attributed to:  Cannabidiol: a novel treatment for cannabis dependence? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2215-0366(20)30290-x

PubMed Identifier: 32735782

Publication URI: http://europepmc.org/abstract/MED/32735782

Type: Journal Article/Review

Volume: 7

Parent Publication: The lancet. Psychiatry

Issue: 10

ISSN: 2215-0366